European Virtual Forum
Thur
. 07 Oct 2021

(All times in Central European Summer Time)

Thanks to the generosity of our sponsors, our 2021 forums were completely complimentary to attend.


 

12:30 - 12:40

Welcome from the Co-chairs

Co-chairs

Keith Barton
Kuldev Singh

12:40 - 12:50

Market overview

Chair

Mike Giaquinto

12:50 - 13:20

Panel 1: Lower Cost Capsulotomy Alternatives to Femto: Are they making an Impact?

Co-chairs

Soon-Phaik Chee
Jorge Alio

Panel

Vance Thompson
Sunil Shah
Richard Packard
Erik Mertens
Todd Pinkney

13:20 - 13:50

Panel 2: The Future of Myopia Treatment - Optical or Pharma?

Chair

Marcus Ang

Panel

Reza Haque
Olga Prenat
Kelly Gottfried
Stephen Newman
Dirk Muehlhoff

13:50 - 14:20

Panel 3: Surgical and Pharmaceutical Approaches to Corneal Endothelial Disease

Co-chairs

Kathryn Colby
Jodbhir Singh Mehta

Panel

Greg Kunst
Robert Warner
Gerd Auffarth
Elizabeth Yeu
Martin Dirisamer
José Guell

14:20 - 15:20

Company presentations 1

Companies

Aurion Biotech | Greg Kunst
Eye-Yon Medical | Yishai Potack
Recornea | Emiliano Lepore
TECLens, LLC | Patrick Lopath
CorNeat Vision Ltd | Almog Aley-Raz
Dopavision | Hamed Bahmani
Plano | Mohamed Dirani

15:20 - 15:35

Corporate Leader Interview 1: How we will Emerge Stronger Post Pandemic

Panel

Shigeo Taniuichi
CEO of Santen, interviewed by Kuldev Singh

15:35 - 16:05

Panel 4: Intravitreal, Intracameral and Extraocular Drug Delivery for Anterior Segment: Which Approach is Best?

Chair

Jonathan Crowston

Panel

Mike Robinson
Mike Goldstein
Parisa Zamiri
Joseph Panarelli

16:05 - 17:10

Company presentations 2

Companies

Ocuphire Pharma | Mina Sooch
Eximore Ltd | Eyal Sheetrit
Mitotech S.A. | Natalia Perekhvatova
Tarsier Pharma | Daphne Haim Langford
Photon Therapeutics Ltd | Sunil Shah
NovaSight | Ran Yam
Medevise Consulting SAS | Kristine Morrill

17:10 - 17:40

Panel 5: The Ophthalmic Sector: Does Past Return on Investment Justify Future Optimism?

Co-chairs

Kuldev Singh
Andy Corley

Panel

Peter Sallstig
Scott Meyer
Jane Rady
Bruce Robertson

17:40 - 18:20

Panel 6: Intraocular vs Bleb-forming Extraocular Glaucoma Surgery: Where is the Greater Unmet Need and Opportunity?

Co-chairs

Keith Barton
Donald Budenz

Panel

Chelvin Sng
Omar Sadruddin
Cody McKenzie
Brett Trauthen
Patrick Smale
Stefano Gandolfi
Julian-Garcia-Feijoo

18:20 - 19:25

Company Presentations 3

Companies

Advanced Ophthalmic Innovations Pte Ltd | Cherry Khoo
iSTAR Medical | Michel Vanbrabant
Sanoculis | Nir Israeli
Radiance Therapeutics | Laurence Marsteller
EYE TECH CARE | Dietrich Wolf
Rheon Medical | Nikos Stergiopulos
Belkin Vision | Daria Lemann Blumenthal
Sight Sciences | Shawn O’Neil

19:25 - 19:40

Corporate Leader Interview 2: How We Will Emerge Stronger Post-Pandemic

Chair

David Endicott
CEO of Alcon, interviewed by Kuldev Singh

19:40 - 20:10

Panel 7: Opportunities in Ophthalmology - Investors' Perspective

Chair

Katya Smirnyagina

Panel

Wende Hutton
Bram Vanparys
Rusty Kelley
Sabine Dandiguian

20:10 - 20:25

Corporate Leader Interview 3: How We Will Emerge Stronger Post-Pandemic

Panel

Ludwin Monz
CEO of Carl Zeiss Meditec, interviewed by Kuldev Singh

20:25 - 21:05

Company Presentations 4

Companies

GLANCE | George Kong
MONA.health | Olivier Menage
AcuFocus, Inc. | Yari Mitchell
LensGen | Sumit Garg

21:05 - 21:45

Panel 8: Which IOL Would You Want in Your Eye if You Had Cataract Surgery Today?

Co-chairs

David Chang
Arthur Cummings

Panel

Douglas Koch
Sam Masket
Marie-Jose Tassignon
David Spalton
Richard Packard
Steven Schallhorn

21:45 - 22:15

Panel 9: I have an idea. Is there a big eye company left to call?

Chair

Einar Stefánsson

Panel

Eugene de Juan
Chuck Hess
Ken Araki
Andrew Stewart

22:15 - 22:20

Summary & concluding remarks

Co-chairs

Keith Barton
Kuldev Singh

Retina Virtual Forum Programme
Wed
. 08 Sept 2021

(All times in Central European Summer Time)

Thanks to the generosity of our sponsors, our 2021 forums were completely complimentary to attend.

13:50 - 14:00

Welcome from the Co-chairs

Co-chairs

Keith Barton
Kuldev Singh

14:00 - 14:30

Panel 1: Personalized Approach to Back of the Eye Therapeutics

Chair

Adnan Tufail

Panelists

Jill Hopkins
Daniela Ferrara
Jay Duker
Jason Ehrlich
Almira Chabi
Einar Stefánsson

14:30 - 15:00

Gene Therapy and Gene Editing for Rare and Common Retinal Diseases

Co-Chairs

Dominik Fischer
Bart Leroy

Panelists

Olivier Danos
Magali Taiel
Gil Carrasquinho
Thomas Ciulla

15:00 - 16:00

Company Presentations 1

Chairs

REGENXBIO
Stephen Pakola

GenSight Biologics S.A.
Magali Taiel

Eyevensys
Francine Behar-Cohen

IVERIC bio
Pravin Dugel

Santen Cell Therapy
Gil Carrasquinho

ForwardVue Pharma
Alan Franklin

16:00 - 16:30

Panel 3: Dry AMD Therapy: Will we get there and who will pay?

Co-Chairs

Sophie Bakri
Sobha Sivaprasad

Panelists

Keith Lane
Chris Brittain
Melissa Liew
Pravin Dugel
Kourous Rezaei

16:30 - 17:10

Panel 4: Investment Update Presentation and Panel Discussion

Chair

Michael Giaquinto, SVB Leerink, New York

Panelists

Geert-Jan-Mulder
Begoña Carreño
Alex Pasteur
Eugene de Juan

17:10 - 18:10

Company Presentations 2

Chair

Ocuphire Pharma
Mina Sooch

OcuTerra Therapeutics
Kerrie Brady

Pleryon Therapeutics
Yu Yu

MONA.health
Olivier Menage

Notal Vision Ltd
Kester Nahen

Visotec GmbH
Helge Sudkamp

18:10 - 18:40

Panel 5: Home Monitoring and Real-World Data to Accelerate Posterior Segment Innovation

Co-Chairs

Usha Chakravarthy
Francesco Bandello

Panelists

Art Ciociola
Kester Nahen
Helge Sudkamp
Angelo Rago
Sally Tucker
Einar Stefánsson
David-Crabb

18:40 - 19:10

Panel 6: Sustained Drug Delivery for AMD: Mainstream Care or an Expensive Side Show

Chair

Ursula Schmidt-Erfurth
Ramin Tadayoni

Panelists

Jaya Chidambaram
Cynthia Grosskreutz
Ram Palanki
Fred Guerrard

19:10 - 19:30

Panel 7: One to one

Kuldev Singh
Anthony Adamis

19:30 - 20:30

Company Presentations 3

Chair

Clearside Biomedical
Thomas Ciulla

EyePoint Pharmaceuticals
Nancy Lurker

Re-Vana Therapeutics
Michael O’Rourke

Samsara Vision
Mike Besserman

Preceyes
Gerrit Naus

20:30 - 21:10

Panel 8: Surgery and Robotics - the Next Frontier?

Co-Chairs

Stan Rizzo
Borja Corcostegui

Panelists

Paul Hallen
Gregg Draudt
Steve Charles
Paulo Stanga
Eugene de Juan

21:00 - 21:10

Summary

Chair

Adnan Tufail

21:10 - 21:15

Concluding remarks from the Co-Chairs

Panelists

Keith Barton
Kuldev Singh


Our Ophthalmology Futures Forums are clinician-driven innovation meetings focusing on new technology, entrepreneurial ventures, market access, and other aspects of commercialisation in the ophthalmic healthcare sector.

They cover all aspects of global innovation in ophthalmic devices, diagnostics, and pharmaceuticals by connecting scientists, physicians, regulators, reimbursement specialists, corporate leaders, venture capitalists, and other investors who support the advancement of eye care.


Thanks to the generosity of our sponsors, registration for our 2021 virtual forums is complimentary for all delegates.

 


 

Sponsorship Opportunities for 2022

Our forum sponsorship opportunities offer organisations of all sizes a unique platform to promote their organisation, products, and services to prominent business and scientific leaders.

If your organisation would be interested in presenting at one of our Forums, please submit your application via the Apply to Present page.

Sponsorship opportunities are available for our European, Asian and Retina Forums or special rates are available for combined sponsorship. Please contact us for further information or for a sponsorship prospectus.

 

 

 


Past 2021 Forums

Asian Forums Virtual

Asian & Asian Retina Forums
Thurs. & Fri. 25 March 2021

2 DAYS
32 START-UP COMPANY PRESENTATIONS
14 PANELS
13 SPONSORS

The 2021 Asian Virtual Forums videos are available here:
Click to view past forums